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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
09.07.2020 Clinical 
characteristics 
of 82 cases of 
death from 
COVID-19 
PLOS One | 
Article 
Older males with comorbidities 
are more likely to develop severe 
disease and even die from 
SARS-CoV-2 infection. 
Respiratory failure is the main 
cause of COVID-19, but the virus 
itself and cytokine release 
syndrome-mediated damage to 
other organs, including cardiac, 
renal, hepatic, and hemorrhagic 
damage, should be taken 
seriously as well. 
Older 
males 
09.07.2020 Persistent 
Symptoms in 
Patients After 
Acute COVID-
19 
JAMA | Article Study assessed persistent 
symptoms in patients who were 
discharged from the hospital 
after recovery from COVID-19 
and found that in patients who 
had recovered from COVID-19, 
87.4% reported persistence of at 
least 1 symptom, particularly 
fatigue and dyspnea. 
Persistent 
symptoms, 
fatigue, 
dyspnea 
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Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
15.07.2020 Comprehensive 
analysis of 
genomic 
diversity of 
SARS-CoV-2 in 
different 
geographic 
regions of 
India: An 
endeavour to 
classify Indian 
SARS-CoV-2 
strains on the 
basis of co-
existing 
mutations 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 This study highlights 
the divergent evolution 
of SARS-CoV-2 strains 
and co-circulation of 
multiple clades in 
India. Monitoring of the 
emerging mutations 
would pave ways for 
vaccine formulation 
and designing of 
antiviral drugs. 
strains 
13.07.2020 Potential 
impact of the 
COVID-19 
pandemic on 
HIV, 
tuberculosis, 
and malaria in 
low-income and 
middle-income 
countries: a 
modelling study 
Lancet Global 
Health | 
Article 
 Study aims to quantify 
the extent to which 
disruptions to services 
for HIV, tuberculosis, 
and malaria in low-
income and middle-
income countries with 
high burdens of these 
diseases could lead to 
additional loss of life 
over the next 5 years. 
 Study finds in high-
burden settings, 
deaths due to HIV, 
tuberculosis, and 
malaria over 5 years 
could increase by up to 
10%, 20%, and 36%, 
respectively, compared 
with if there was no 
COVID-19 pandemic. 
 
Modelling, 
HIV, 
tuberculosis, 
malaria 
15.07.2020 Analysis of 
COVID-19 
cases and 
medRxiv (not 
peer-
 Analysis of COVID-19 
cases and prediction of 
quantity of associated 
ventilator requirement 
is very relevant during 
Ventilator 
3 
associated 
ventilator 
requirement in 
Indian States 
reviewed) | 
pre-print 
this pandemic. This 
paper presents a 
method for predictive 
estimation of ventilator 
requirement for 
COVID-19 patients in 
Indian states. It uses 
ARIMA 
(Autoregressive 
Integrated Moving 
Average) model for 
predicting the future 
cumulative cases and 
daily fatality.  
 Taking cue from this, 
ventilator requirement 
is estimated for each 
state. State wise 
estimation of ventilator 
is important because 
public healthcare 
system in India is 
managed at state level. 
Dataset on Novel 
Corona Disease 2019 
in India from Kaggle 
website is used in this 
work. 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
15.07.2020 Physical 
distancing 
interventions 
and incidence 
of coronavirus 
disease 2019: 
natural 
experiment in 
149 countries 
BMJ | Article 
 Physical distancing 
interventions were 
associated with 
reductions in the 
incidence of covid-19 
globally. No evidence 
was found of an 
additional effect of 
public transport closure 
when the other four 
physical distancing 
measures were in 
place. Earlier 
implementation of 
lockdown was 
associated with a 
larger reduction in the 
incidence of covid-19. 
These findings might 
support policy 
Physical 
distancing 
  
4 
decisions as countries 
prepare to impose or 
lift physical distancing 
measures in current or 
future epidemic waves. 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
15.07.2020 An affordable 
anti- SARS-
COV-2 spike 
ELISA test for 
early detection 
of IgG 
seroconversion 
suited for 
large-scale 
surveillance 
studies in low-
income 
countries 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 We describe a cost-
effective, scalable 
technology to produce 
SARS-COV-2 spike (S) 
protein based on stable 
expression in HEK293 cells, 
and its use to develop a 
highly specific and sensitive 
ELISA test. The assay 
allows early detection of 
anti-S IgG seroconversion 
and endpoint titers correlate 
with virus neutralization. The 
low-cost S-antigen 
production, together with 
sample collection by finger 
prick and dried blood spots, 
allowed the development of 
a half-dollar test that fits the 
urgent need for large-scale 
serological surveillance in 
low-income countries. 
test 
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Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.06.2020 Voices from 
the frontline: 
findings from 
a thematic 
analysis of a 
rapid online 
global survey 
of maternal 
and newborn 
health 
professionals 
facing the 
COVID-19 
pandemic 
BMJ | Article 
 Global, cross-sectional 
study of maternal and 
newborn health 
professionals via an 
online survey 
 714 responses 
 Conclusion: Substantial 
knowledge gaps exist in 
guidance on 
management of 
maternity cases with or 
without COVID-19. 
Formal information-
sharing channels for 
providers must be 
established and mental 
health support provided. 
Surveys of maternity 
care providers can help 
track the situation, 
capture innovations and 
support rapid 
development of effective 
responses. 
maternity 
10.07.2020 Exploring 
COVID-19 
stress and its 
factors in 
Bangladesh: 
A perception-
based study 
Heliyon 
 An online based survey 
was carried out among 
340 Bangladeshi adults. 
 About 85.60% of the 
participants are in 
COVID-19-related 
stress, which results in 
sleep shortness, short 
temper, and chaos in 
family. Fear of COVID-
19 infection (i.e., self 
and/or family 
member(s), and/or 
relatives), hampering 
scheduled study plan 
and future career, and 
financial difficulties are 
identified as the main 
causes of human stress. 
Stress, 
Bangladesh 
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Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
15.07.2020 Covid-19 
response 
in Sub-
Saharan 
Africa: 
lessons 
from 
Uganda 
Disaster 
Medicine and 
Public Health 
Preparedness 
 The prolongation of the 
Ebola epidemic may have 
allowed some countries to 
prepare and respond to the 
COVID-19 outbreak. In 
Uganda, the surveillance 
structure built for Ebola Virus 
Disease(EVD) has become a 
pillar in the COVID-19 
response. This testing and 
tracing apparatus has limited 
disease spread to clusters 
with zero mortality compared 
to her East African 
neighbours. As more sub-
Saharan countries implement 
social distancing to contain 
the outbreak, the 
interventions should be 
phased and balanced with 
health risk and socio-
economic situation. However, 
having a decision-making 
matrix would guide the 
response team better. These 
initial lessons from EVD 
experienced Uganda may be 
helpful to other countries in 
the region. 
Uganda 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
15.07.2020 Systems and 
implementation 
science should 
be part of the 
COVID-19 
response in low 
resource 
settings 
BMC Medicine 
 Researchers should be 
as rigorous as possible 
in designing, conducting 
and reporting their work 
with the specific purpose 
of generating needed 
inputs to local policy as 
well as generalizable 
insights. Generating 
transferable knowledge 
would be facilitated by 
multi-country research 
  
7 
collaborations that share 
expertise, methods and 
priorities as WHO is 
promoting through the 
Quality of Care Network 
focused on peripartum 
care.  
 Another such initiative is 
the proposed QuEST 
Network, a follow-on 
body to the Lancet 
Global Health 
Commission on High 
Quality Health Systems. 
Such consortia may 
provide models for jointly 
tackling large-scale, 
high-priority research 
that supports health 
system reform toward 
high-quality, people-
centred care during and 
after the COVID-19 
pandemic. In promoting 
and conducting such 
work, there is an 
opportunity to build much 
needed capacity 
amongst LRS scientists 
and foster the continued 
growth of fields that the 
COVID-19 pandemic 
illustrates are key to 
supporting evidence-
informed high-quality 
health systems in the 
long run. 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
09.07.2020 COVID-19 Testing in the Philippines: Enhancing 
Testing Productivity  
BMJ | Blog 
10.07.2020 Community health workers reveal COVID-19 
disaster in Brazil 
 Lancet | Comment 
09.07.2020 The Lancet COVID-19 Commission Lancet |Comment 
8 
09.07.2020 COVID-19 in northern Uganda: Resistance, 
defiance and hospitalising asymptomatic cases  
BMJ | Blog 
09.07.2020 The Lancet COVID-19 Commission Lancet |Comment 
12.07.2020 A crisis of accountability for women's, children's, 
and adolescents' health 
Lancet | Comment 
10.07.2020 The mathematical strategy that could transform 
coronavirus testing 
Nature | News 
09.07.2020 Covid-19: Deaths in Mexico triple since 
reopening began in June 
BMJ | News 
07.07.2020 Pre-existing immunity to SARS-CoV-2: the 
knowns and unknowns 
Nature | Comment 
10.07.2020 Cities — try to predict superspreading hotspots 
for COVID-19 
Nature | Comment 
15.07.2020 Time Is Brain: A Call to Action to Support Stroke 
Centers in Low- and Middle-Income Countries 
during the COVID-19 Pandemic 
Clinical Neurology | Letter  
14.07.2020 Overlapping of locust swarms with COVID-19 
pandemic: a cascading disaster for Africa 
Pathogens and Global 
Health |Commentary 
14.07.2020 Emergency Care Systems: The missing link for 
effective treatment of COVID-19 in Africa 
Disaster Medicine and 
Public Health Preparedness 
14.07.2020 COVID-19 outbreak and decreased 
hospitalisation of pregnant women in labour 
Lancet Global Health | 
Comment 
15.07.2020 Plug COVID-19 research gaps in detection, 
prevention and care 
Nature | World View 
14.07.2020 Dexamethasone for COVID-19: data needed from 
randomised clinical trials in Africa 
Lancet Global Health | 
Commentary 
9 
13.07.2020 HIV, tuberculosis, and malaria: how can the 
impact of COVID-19 be minimised? 
Lancet Global Health | 
Comment 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
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Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
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(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
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Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
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19 
  Solidarity 
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 COVID-
19 Oxford 
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 Oxford C19 
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COVID-
evidence 
      
Global 5050 
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COVID-19 
Policy 
Response 
Portal 
Cochrane       
10 
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
11 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
12 
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
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GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
14 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
15 
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
 The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. It is 
licensed for non-commercial purposes only. K4D cannot be held responsible for errors, 
omissions or any consequences arising from the use of information contained in this health 
evidence summary. Any views and opinions expressed do not necessarily reflect those of 
DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020.               
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